APA (7th ed.) Citation

Yu, B. (2025). Leveraging glypican-3 (GPC3)-mediated lysosome-targeting chimeras (GLTACs) for targeted membrane protein degradation. Acta pharmaceutica Sinica. B, 15(4), 2293-2294. https://doi.org/10.1016/j.apsb.2025.03.044

Chicago Style (17th ed.) Citation

Yu, Bin. "Leveraging Glypican-3 (GPC3)-mediated Lysosome-targeting Chimeras (GLTACs) for Targeted Membrane Protein Degradation." Acta Pharmaceutica Sinica. B 15, no. 4 (2025): 2293-2294. https://doi.org/10.1016/j.apsb.2025.03.044.

MLA (9th ed.) Citation

Yu, Bin. "Leveraging Glypican-3 (GPC3)-mediated Lysosome-targeting Chimeras (GLTACs) for Targeted Membrane Protein Degradation." Acta Pharmaceutica Sinica. B, vol. 15, no. 4, 2025, pp. 2293-2294, https://doi.org/10.1016/j.apsb.2025.03.044.